Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Extremities Neoplasms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8576 Neoplasms 6589 Carcinoma, Non-Small-Cell Lung 4814 Prostatic Neoplasms 4251 Colorectal Neoplasms 3850 Lung Neoplasms 3104 Leukemia, Myeloid, Acute 2617 Neoplasm Metastasis 2608 Multiple Myeloma 2591 Pancreatic Neoplasms 2423 Melanoma 2236 Ovarian Neoplasms 2184 Lymphoma 2177 Carcinoma, Hepatocellular 2088 Stomach Neoplasms 1976 Recurrence 1872 Head and Neck Neoplasms 1760 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1748 Lymphoma, Non-Hodgkin 1733 Leukemia 1722 Brain Neoplasms 1633 Glioblastoma 1528 Colonic Neoplasms 1504 Leukemia, Lymphocytic, Chronic, B-Cell 1476 Rectal Neoplasms 1456 Uterine Cervical Neoplasms 1400 Lymphoma, Follicular 1377 Squamous Cell Carcinoma of Head and Neck 1371 Lymphoma, Large B-Cell, Diffuse 1351 Carcinoma, Renal Cell 1312

Interventions

Electroporation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430688 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Extremities Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡